These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 22154856)

  • 41. Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient.
    Rodríguez-Avial C; Rodríguez-Avial I; Merino P; Picazo JJ
    Clin Microbiol Infect; 2012 Jan; 18(1):61-6. PubMed ID: 21722259
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Susceptibility of Klebsiella spp. to tigecycline and other selected antibiotics.
    Sekowska A; Gospodarek E
    Med Sci Monit; 2010 Jun; 16(6):BR193-6. PubMed ID: 20512088
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outbreak of KPC-3-producing, and colistin-resistant, Klebsiella pneumoniae infections in two Sicilian hospitals.
    Mezzatesta ML; Gona F; Caio C; Petrolito V; Sciortino D; Sciacca A; Santangelo C; Stefani S
    Clin Microbiol Infect; 2011 Sep; 17(9):1444-7. PubMed ID: 21668577
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy.
    Kang CI; Chung DR; Ko KS; Peck KR; Song JH;
    Ann Hematol; 2012 Jan; 91(1):115-21. PubMed ID: 21556875
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Outbreak of carbapenem-resistant enterobacteriaceae containing blaNDM-1, Ontario, Canada.
    Borgia S; Lastovetska O; Richardson D; Eshaghi A; Xiong J; Chung C; Baqi M; McGeer A; Ricci G; Sawicki R; Pantelidis R; Low DE; Patel SN; Melano RG
    Clin Infect Dis; 2012 Dec; 55(11):e109-17. PubMed ID: 22997214
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Three Dimensional Checkerboard Synergy Analysis of Colistin, Meropenem, Tigecycline against Multidrug-Resistant Clinical Klebsiella pneumonia Isolates.
    Stein C; Makarewicz O; Bohnert JA; Pfeifer Y; Kesselmeier M; Hagel S; Pletz MW
    PLoS One; 2015; 10(6):e0126479. PubMed ID: 26067824
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antimicrobial susceptibility of extended-spectrum beta-lactamase producers and multidrug-resistant Acinetobacter baumannii throughout the United States and comparative in vitro activity of tigecycline, a new glycylcycline antimicrobial.
    Hoban DJ; Bouchillon SK; Dowzicky MJ
    Diagn Microbiol Infect Dis; 2007 Apr; 57(4):423-8. PubMed ID: 17403448
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outbreak of Klebsiella pneumoniae carbapenemase-2-producing K. pneumoniae sequence type 11 in Taiwan in 2011.
    Lee CM; Liao CH; Lee WS; Liu YC; Mu JJ; Lee MC; Hsueh PR
    Antimicrob Agents Chemother; 2012 Oct; 56(10):5016-22. PubMed ID: 22802253
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tigecycline for treatment of pneumonia and empyema caused by carbapenemase-producing Klebsiella pneumoniae.
    Daly MW; Riddle DJ; Ledeboer NA; Dunne WM; Ritchie DJ
    Pharmacotherapy; 2007 Jul; 27(7):1052-7. PubMed ID: 17594211
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan.
    Liu HY; Lin HC; Lin YC; Yu SH; Wu WH; Lee YJ
    J Microbiol Immunol Infect; 2011 Oct; 44(5):364-8. PubMed ID: 21524974
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro activity of tigecycline and comparators against Gram-negative pathogens isolated from blood in Europe (2004-2009).
    Andrasevic AT; Dowzicky MJ
    Int J Antimicrob Agents; 2012 Feb; 39(2):115-23. PubMed ID: 22189391
    [TBL] [Abstract][Full Text] [Related]  

  • 52. blaNDM-1 Carriage on IncR Plasmid in Enterobacteriaceae Strains.
    Kocsis E; Gužvinec M; Butić I; Krešić S; Crnek SŠ; Tambić A; Cornaglia G; Mazzariol A
    Microb Drug Resist; 2016 Mar; 22(2):123-8. PubMed ID: 26484384
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regional variations in multidrug resistance among Enterobacteriaceae in the USA and comparative activity of tigecycline, a new glycylcycline antimicrobial.
    DiPersio JR; Dowzicky MJ
    Int J Antimicrob Agents; 2007 May; 29(5):518-27. PubMed ID: 17376657
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of Monte Carlo simulation to evaluate the efficacy of tigecycline and minocycline for the treatment of pneumonia due to carbapenemase-producing Klebsiella pneumoniae.
    Ni W; Li G; Zhao J; Cui J; Wang R; Gao Z; Liu Y
    Infect Dis (Lond); 2018 Jul; 50(7):507-513. PubMed ID: 29316830
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of synergism between colistin, fosfomycin and tigecycline against extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates or with carbapenem resistance.
    Ku YH; Chen CC; Lee MF; Chuang YC; Tang HJ; Yu WL
    J Microbiol Immunol Infect; 2017 Dec; 50(6):931-939. PubMed ID: 28716360
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 beta-lactamase resistant to colistin.
    Kontopoulou K; Protonotariou E; Vasilakos K; Kriti M; Koteli A; Antoniadou E; Sofianou D
    J Hosp Infect; 2010 Sep; 76(1):70-3. PubMed ID: 20705205
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence and antimicrobial resistance patterns of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in an Istanbul University Hospital.
    Koksal F; Ak K; Kucukbasmaci O; Samasti M
    Chemotherapy; 2009; 55(4):293-7. PubMed ID: 19521075
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro and in vivo activities of tigecycline-colistin combination therapies against carbapenem-resistant Enterobacteriaceae.
    Betts JW; Phee LM; Hornsey M; Woodford N; Wareham DW
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3541-6. PubMed ID: 24687491
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High Prevalence of New Delhi Metallo-β-Lactamase-1 (NDM-1) Producers among Carbapenem-Resistant Enterobacteriaceae in Kuwait.
    Jamal WY; Albert MJ; Rotimi VO
    PLoS One; 2016; 11(3):e0152638. PubMed ID: 27031521
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tigecycline displays in vivo bactericidal activity against extended-spectrum-β-lactamase-producing Enterobacteriaceae after 72-hour exposure period.
    Tessier PR; Nicolau DP
    Antimicrob Agents Chemother; 2013 Jan; 57(1):640-2. PubMed ID: 23114764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.